Vertex Pharmaceuticals Incorporated
General ticker "VRTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $117.9B
Vertex Pharmaceuticals Incorporated follows the US Stock Market performance with the rate: 49.1%.
Estimated limits based on current volatility of 1.8%: low 391.08$, high 407.86$
Factors to consider:
- Company included in S&P500 list
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [274.09$, 425.35$]
- 2024-12-30 to 2025-12-30 estimated range: [285.79$, 443.72$]
Financial Metrics affecting the VRTX estimates:
- Positive: Non-GAAP EPS, $ of 14.94 > 2.29
- Negative: Inventory ratio change, % of 2.19 > 1.08
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Return on assets ratio (scaled to [-100,100]) of 13.74 > 7.10
- Negative: Investing cash flow per share, $ of -12.19 <= -3.48
- Positive: Operating profit margin, % of 38.83 > 19.51
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Negative: 0.14 < Interest expense per share, $ of 0.17
Short-term VRTX quotes
Long-term VRTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $7,574.40MM | $8,930.70MM | $9,869.20MM |
| Operating Expenses | $4,792.30MM | $4,623.30MM | $6,037.20MM |
| Operating Income | $2,782.10MM | $4,307.40MM | $3,832.00MM |
| Non-Operating Income | $-51.70MM | $-75.00MM | $547.80MM |
| Interest Expense | $61.50MM | $54.80MM | $44.10MM |
| R&D Expense | $3,051.10MM | $2,540.30MM | $3,162.90MM |
| Income(Loss) | $2,730.40MM | $4,232.40MM | $4,379.80MM |
| Taxes | $388.30MM | $910.40MM | $760.20MM |
| Profit(Loss) | $2,342.10MM | $3,322.00MM | $3,619.60MM |
| Stockholders Equity | $10,100.00MM | $13,912.70MM | $17,580.40MM |
| Inventory | $353.10MM | $460.60MM | $738.80MM |
| Assets | $13,432.50MM | $18,150.90MM | $22,730.20MM |
| Operating Cash Flow | $2,643.50MM | $4,129.90MM | $3,537.30MM |
| Capital expenditure | $235.00MM | $204.70MM | $258.40MM |
| Investing Cash Flow | $-340.90MM | $-321.10MM | $-3,141.70MM |
| Financing Cash Flow | $-1,478.00MM | $-67.70MM | $-562.20MM |
| Earnings Per Share* | $9.09 | $12.97 | $14.05 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.